immune system
N |
• mice exhibit normal frequencies of conventional dendritic cells and plasmacytoid dendritic cells in the bone marrow and spleen
|
• moderate reduction in the frequency of naive T cells in the spleen
• however, regulatory T cell frequencies are normal
|
• reduced frequency of IFNG+ Th1 cells in mice treated with MOG(35-55) along with pertussis toxin
• reduced frequency of Th1 cells in draining lymph nodes and spleen in mice treated with MOG(35-55) along with pertussis toxin
|
• reduced frequency of IL17+Th17 cells in mice treated with MOG(35-55) along with pertussis toxin
• reduced frequency of Th17 cells in draining lymph nodes and spleen in mice treated with MOG(35-55) along with pertussis toxin
|
• in mice treated with MOG(35-55) along with pertussis toxin
|
• in mice treated with MOG(35-55) along with pertussis toxin
|
• mice treated with MOG(35-55) along with pertussis toxin exhibit delayed onset, decreased clinical score and reduced inflammation compared with wild-type mice
|
homeostasis/metabolism
• in mice treated with MOG(35-55) along with pertussis toxin
|
• in mice treated with MOG(35-55) along with pertussis toxin
|
hematopoietic system
• moderate reduction in the frequency of naive T cells in the spleen
• however, regulatory T cell frequencies are normal
|
• reduced frequency of IFNG+ Th1 cells in mice treated with MOG(35-55) along with pertussis toxin
• reduced frequency of Th1 cells in draining lymph nodes and spleen in mice treated with MOG(35-55) along with pertussis toxin
|
• reduced frequency of IL17+Th17 cells in mice treated with MOG(35-55) along with pertussis toxin
• reduced frequency of Th17 cells in draining lymph nodes and spleen in mice treated with MOG(35-55) along with pertussis toxin
|